As you may know, 23andMe collects and holds sensitive, immutable, identifiable personal information about millions of ...

Genetic testing company 23andMe has filed for bankruptcy after struggling with financial difficulties and strategic missteps.

Me might have filed for bankruptcy, but the transformation it brought to health care over nearly two decades is irreversible, ...

The collapse of 23andMe is sparking important conversations — and unanswered questions — about genetic data privacy and ...

The possibility of new ownership over 23andMe has some customers concerned about how their sensitive genetic information will ...

Since genetics testing firm 23andMe filed for Chapter 11 bankruptcy protection and said it would seek to sell its assets, ...

A Strategic Move? The Chapter 11 filing indicates that 23andMe will enter a court-supervised sale or auction of its assets. Mark Jensen, a board member, has stated that this is the "best path forward ...

In a shocking development for investors and fans of genetic testing, 23andMe (ME) shares are plummeting, set to open around $1 this Monday morning after the company filed for Chapter 11 bankruptcy.

So it wasn't a big surprise that after the failure of a last-ditch bid by the CEO to take the company private, 23andMe ultimately filed for Chapter 11 bankruptcy protection in late March ...